HMGB1 and Stroke: For example, in animal models of stroke, HMGB1 is released rapidly before pronounced cell death [41] and treatment with neutralizing HMGB1 antibodies or HMGB1 inhibitor glycyrrhizin reduces ischemia-induced neuroimmune gene induction and brain damage [42], [43], [44] as well as spinal cord damage [44].